Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from WuhanHeng Zhai, Yinzhang Lv, Yu Xu et al.|Journal of Neural Transmission|2021Cited by 22
Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-ReviewYi Wu, Yan Xu, Xiaoqian Zhang et al.|Frontiers in Neurology|2021Cited by 14
AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesiaKe Liu, Xuebing Cao, Zhaoyuan Zhang et al.|Cellular Signalling|2024Cited by 7
Integrated PET/MRI With 11C-CFT and 18F-FDG for levodopa response difference in Parkinson’s diseaseYi Wu, Yan Xu, Xiaojun Xu et al.|Behavioural Brain Research|2023Cited by 2
Clinical Features and Outcomes of Parkinson's Disease with Coronavirus Disease 2019 (COVID-19) in Wuhan: A Single Center, Retrospective, Observational StudyHeng Zhai, Yan Xu, Yinzhang Lv et al.|SSRN Electronic Journal|2020Cited by 1